InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference | NSPR Stock News
InspireMD, Inc. (Nasdaq: NSPR) announced its participation in the Piper Sandler 37th Annual Healthcare Conference on December 3rd, 2025. The company will engage in a fireside discussion, accessible via live audio webcast and replay on its website. InspireMD aims to establish its MicroNet™ mesh technology as the industry standard for carotid stenting. For more information, visit their website or contact their investor relations.
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to participate in a fireside discussion at the upcoming Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3rd at 12:30 pm Eastern Time (ET).
A live audio webcast and replay of the discussion may be accessed on the “Investor Calendar” section of the company’s website at: https://event.webcasts.com/starthere.jsp?ei=1744172&tp_key=a1a6262ba9
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com
